Related Experiment Video
Updated: Jun 3, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Unraveling 'F' factor: towards a genetic-clinical framework for the musculoskeletal-heart crosstalk in metabolic
Yunqiao Zhou1, Jian Huang1, Xinyi Chen1
1Orthopedics Section 1, Dongzhimen Hospital of Beijing University of Chinese Medicine, No. 5 Haiyuncang Hutong, Dongcheng District, Beijing, 100700, China.
Insights
A new "F" factor links heart and bone aging, improving risk prediction for cardiometabolic multimorbidity. This discovery aids early detection and prevention of age-related diseases.
Area of Science:
- Gerontology
- Genetics
- Cardiology
Background:
- Cardiometabolic diseases and musculoskeletal degeneration often co-occur, posing challenges to healthy aging.
- Shared biological mechanisms linking these conditions are not well understood.
Purpose of the Study:
- To develop an integrative clinical-genetic framework to identify a common frailty factor ('F' factor).
- To elucidate the 'F' factor's role in systemic vulnerability connecting cardiometabolic multimorbidity (CMM) and musculoskeletal aging.
Main Methods:
- Utilized the China Health and Retirement Longitudinal Study (CHARLS) cohort.
- Developed and validated Frailty-Integrated Indices for CMM risk prediction using machine learning.
- Applied Genomic Structural Equation Modeling (Genomic-SEM) to model a shared latent genetic factor ('F' factor) integrating multiple traits.
Main Results:
- Frailty-Integrated Indices significantly improved CMM risk prediction (AUC=0.727).
- Identified a significant shared genetic factor ('F' factor) with novel risk loci, including APOE and SLC22A3.
- Genes implicated in cellular senescence and cholesterol metabolism, with specific expression in endothelial cells.
Conclusions:
- Converging evidence supports Musculoskeletal-Heart crosstalk in metabolic aging.
- The 'F' factor is a genetic correlate of a transdiagnostic state linking genetic predisposition to metabolic dysregulation and functional decline.
- This research aids multi-level characterization of multimorbidity liability for early risk detection and prevention.
Background:
The rising co-occurrence of cardiometabolic diseases and musculoskeletal degeneration poses a critical challenge to healthy aging, yet the shared biological mechanisms underlying this multimorbidity remain poorly defined. This study aimed to establish an integrative clinical-genetic framework to elucidate the common frailty factor, the 'F' factor, that captures the systemic vulnerability linking cardiometabolic multimorbidity (CMM) and musculoskeletal aging.
Methods:
Utilizing the prospective China Health and Retirement Longitudinal Study (CHARLS) cohort, we developed and validated novel Frailty-Integrated Indices for CMM risk prediction, evaluated with machine learning models interpreted via SHapley Additive exPlanations (SHAP). Independently, we applied genomic structural equation modeling (Genomic-SEM) to integrate genome-wide association data from six traits-coronary artery disease, type 2 diabetes, hypertension, bone mineral density, frailty, and telomere length-to model a shared latent genetic factor ('F' factor). This was followed by multivariate GWAS, fine-mapping, transcriptome-wide association study (TWAS), gene-based analysis, and functional annotation to prioritize causal genes, pathways, and cell types.
Results:
Clinically, several Frailty-Integrated Indices significantly improved CMM risk prediction, with the optimal model achieving an AUC of 0.727. Genetically, we modeled a significant shared latent genetic factor ('F' factor), pinpointing novel risk loci and implicating key genes such as APOE and SLC22A3. These genes were enriched in pathways including cellular senescence and cholesterol metabolism and showed specific expression patterns in developmental brain stages and across multi-organ endothelial cells.
Conclusion:
Our findings provide converging evidence for Musculoskeletal‑Heart crosstalk of metabolic aging and inferred the 'F' factor as a genetic correlate of a transdiagnostic state, which links genetic predisposition to metabolic dysregulation, and systemic functional decline. This work provides a multi-level biological characterization of multimorbidity liability, informing early-risk detection and preventive strategies for complex aging-related comorbidities.
Related Concept Videos
Mitochondria
The Effect of Aging on Tissues
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Pathophysiology of Heart Failure
Pathophysiology of Cardiac Performance
